ProcartaPlex™ Human Immune Monitoring Panel, 65plex
ProcartaPlex™ Human Immune Monitoring Panel, 65plex
Invitrogen™

ProcartaPlex™ Human Immune Monitoring Panel, 65plex

ヒト免疫法モニタリング65-Plex ProcartaPlexパネルは、Luminex xMAPクノロジーを使用して、1つのウェルで65個のタンパク質ターゲットを分析することにより、免疫機能の研究を可能にします。効率的な免疫応答プロファイリング、バイオマーカー探索、および検証のために65種類のサイトカイン、ケモカイン詳細を見る
製品番号(カタログ番号)数量
EPX650-10065-90196テスト
製品番号(カタログ番号) EPX650-10065-901
価格(JPY)
1,722,000
Each
お問い合わせください ›
数量:
96テスト
ヒト免疫法モニタリング65-Plex ProcartaPlexパネルは、Luminex xMAPクノロジーを使用して、1つのウェルで65個のタンパク質ターゲットを分析することにより、免疫機能の研究を可能にします。効率的な免疫応答プロファイリング、バイオマーカー探索、および検証のために65種類のサイトカイン、ケモカイン、増殖因子ターゲットを同時に分析します。パネルは、1X濃度で調製されたキャプチャーおよび検出試薬のバイアルを個別に含むすぐに使用可能なフォーマットで提供されており、ピペット操作や実験のセットアップが必要性が少なくなります。このキットはMAGPIX機器には対応していません。MAGPIXユーザーは、MAGPIX用ヒト免疫モニタリング65 Plexパネル(カタログ番号EPX650-16500-901)を使用する必要があります。これは、MAGPIX機器で使用するために特別に設計された43-Plexキットと22-Plexキットの2つのキットで構成されており、最大50個のターゲットを同時に検出できます。

ProcartaPlex事前設定済みパネルは、検体の組み合わせ性、干渉、交差反応性について広範にテストされており、最高レベルの検証と精度を提供します。すべての ProcartaPlex パネルには、アッセイの実行に必要な試薬が付属しています。

ProcartaPlexマルチプレックスパネルは、6 種の生物種(ヒト、マウス、ラット、ヒト以外の霊長類、ブタ、イヌ)にわたって複数のフォーマットで利用可能です。

ターゲット[ビーズ領域]:

サイトカイン:G-CSF(CSF-3)[42]、GM-CSF [44]、IFNα[48]、IFNγ[43]、IL-1α[62]、IL-1β[18]、IL-2 [19]、IL-3 [73]、IL-4 [20]、IL-5 [21]、IL-6 [25]、IL-7 [26]、IL-8(CXCL8)[27]、IL-9 [52]、IL-10 [28]、IL-12p70 [34]、IL-13 [35]、IL-15 [65]、IL-16 [70]、IL-17A(CTLA-8)[36]、IL-18 [66]、IL-20 [81]、IL-21 [72]、IL-22 [76]、IL-23 [63]、IL-27 [14]、IL-31 [37]、LIF [15]、M-CSF [67]、MIF [53]、TNFα[45]、TNFβ[54]、TSLP [80]

ケモカイン:BLC (CXCL13) [29]、ENA-78 (CXCL5) [82]、エオタキシン(CCL11)[33]、エオタキシン-2(CCL24)[37]、エオタキシン-3(CCL26)[77]、フラクタルカイン(CX3CL1)[59]、Gro-α(CXCL1)[61]、IP-10 (CXCL10) [22]、I-TAC (CXCL11) [57]、MCP-1 (CCL2) [51]、MCP-2 (CCL8) [8]、MCP-3 (CCL7) [68]、MDC (CCL22) [87]、MIG (CXCL9) [69]、MIP-1α(CCL3)[12]、MIP-1β(CCL4)[47]、MIP-3α(CCL20)[56]、SDF-1α(CXCL12)[13]

増殖因子/調節因子:FGF-2 [75]、HGF [46]、MMP-1 [64]、NGFβ[55]、SCF [39]、VEGF-A [78]

可溶性受容体:APRIL [88]、BAFF [86]、CD30 [84]、CD40L(CD154)[74]、IL-2R(CD25)[22]、TNF-RII [85]、TRAIL(CD253)[58]、TWEAK [97]

Luminexプラットフォーム用ProcartaPlexアッセイについて
ProcartaPlexイムノアッセイは、サンドイッチELISAの原則に基づいており、1つのタンパク質の複数のエピトープに結合した2つの特異的抗体を使用して、すべてのタンパク質ターゲットを同時に定量化します。ProcartaPlex マルチプレックスアッセイは、わずか 25 µL の血漿または血清、あるいは 50 µL の細胞培養上清のみを必要とし、分析結果を得るために要する時間もわずか 4 時間です。

次の特長があります。
• タンパク質標的の結合性や交差反応性試験など、業界最高水準のパネルとして検証された再現性と信頼性の高い結果
• 1つのサンプルあたりより多くの結果—25~50 µLの1つのサンプルで複数のタンパク質標的を同時に測定します
• タンパク質の検出および定量化のためのL確立されたLuminexテクノロジーを使用した高度な参照マルチプレックスプラットフォーム

ProcartaPlexアッセイでは、1つの25~50 µLのサンプルで血漿、血清、細胞培養上清、その他の体液から、—最大65個のタンパク質標的の同時検出および定量化のために、Luminex xMAP(多項目同時測定プロファイリング)テクノロジーを利用します。
研究用途にのみご使用ください。診断目的には使用できません。
仕様
アッセイ範囲分析証明書を参照
アッセイ感度15%未満
検出法Fluorescence
使用対象 (装置)Luminex™ 装置
フォーマットMultiplex Kit
製品ラインProcartaPlex
サンプルタイプ血清、血漿、細胞培養上清, Plasma, Cell Culture Supernatants
サンプル量血清、血漿:25 μL、CCS:50 μL
出荷条件湿氷
CombinabilityNon-Combinable
製品タイプマルチプレックスパネル
数量96テスト
Research AreaImmunology
Human
Unit SizeEach
組成および保存条件
  • ヒト標準ミックスM(凍結乾燥)バイアル2本
  • キャプチャービーズミックス(1X)バイアル1本
  • ビオチン化検出抗体ミックス(1X)バイアル1本
  • ヒトコントロール-Highバイアル2本
  • ヒトコントロール-Lowバイアル2本
  • 読み取りバッファー(1X)ボトル1本
  • 洗浄バッファー(10X)ボトル1本
  • ストレプトアビジン-PE(1X)ボトル1本
  • ユニバーサルアッセイバッファー(1X)ボトル1本
  • 8チューブストリップ
  • 接着フィルム
  • 平底96ウェルプレート、黒
  • 2℃~8℃で保存してください

よくあるご質問(FAQ)

What is the size of the Luminex beads you currently use?

The beads used in our Luminex instrument-compatible ProcartaPlex and QuantiGene Plex assays are 6.5 micron superparamagnetic beads.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

I am interested in performing Luminex assays using BioSource kits, and I have a Luminex xMAP system. Besides the kits and system, what other reagents and equipment will I need?

The following is a list of general lab supplies that are required for running BioSource immunoassays on the Luminex xMAP system:
1) Sonicating water bath
2) Orbital shaker
3) Vortexer
4) Repeating and/or multi-channel pipetter (not required, but recommended)
5) Calibrated adjustable precision pipettes, with disposable plastic tips
6) Glass/plastic tubes and racks for preparing reagents
7) Graduated cylinder and container for preparing wash solution
8) Aluminum foil
9) Deionized or distilled water.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Do the Luminex beads require special care in handling?

The Luminex beads should be protected from light because they are susceptible to photobleaching. We recommend protecting the beads by keeping containers covered with aluminum foil during all incubation steps, and exercising care during handling. The beads should not be frozen, subjected to excessive heat, or exposed to organic solvents.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Why would the Luminex acquisition software display "Sample Empty" messages during analysis?

(1) The user did not properly aliquot the diluted beads, such that no beads were actually added to the wells (make sure that the bead concentrates are sonicated and vortexed well, then check the pipet tip to ensure that air bubbles were not drawn up)
(2) The user missed loading diluted beads to some wells, which is likely since the small volume is clear and difficult to visualize in the clear plastic plate (we have now addressed this customer difficulty by coloring each of the Buffer Reagent Kit components)
(3) The user applied too much vacuum pressure at some point during the wash steps, or allowed the pressure to spike even once, such that the filter membrane tore in a few wells releasing the beads (make sure that the vacuum manifold pressure is kept below 5mm/in Hg, depending on their system -- a good rule of thumb is that it should take a full 3-second count to GENTLY empty the wells of 200uL)
(4) The user did not properly sonicate and vortex the beads prior to dilution, such that the percent of bead aggregation was high and the instrument was unable to find enough single beads to meet the events/bead value designated by the customer (make sure that the Bead Concentrate tube is put into the waterbath all the way to the cap, since the tube is hollow until the top third)
(5) The user lost beads by shaking the plate too aggressively or handling it improperly (make sure that the orbital shaker is set to a speed that allows for maximum vortex in the wells without spillage)
(6) The user exposed the beads to an excess of light during storage or running of the assay, such that some but not all of the beads were photobleached and therefore falling outside the acceptable range for each bead region (make sure that the plate is covered on the top/sides with foil throughout the assay, away from Windows and spotlights, and that the bead component of the kits is stored in the dark)*
(7) There was a clog in the sample needle, such that the instrument was unable to take up enough sample to meet the number of events requested per bead region (suggest that the user follow the manual instructions for dislodging a clog, which include several Back Flush steps and may require removal of the needle for sonication with probe alignment).

* Some of the older Antibody Bead Kits still have clear plastic tops instead of black ones. In cases where customers store kits in lit refrigerators, or keep them open on the lab bench, even a few hours of light exposure is enough to photobleach beads. It is important to note, in general, that higher number bead regions are more susceptible to photobleaching. In order to draw conclusions about the source of the difficulty, we would ask to see the data, specifically the Masterplex QT file, which would enable us to examine the pattern of "Sample Empty" occurrences in addition to the bead counts per well.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

What are the Luminex beads made of?

The beads are made of polystyrene.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

引用および参考文献 (13)

引用および参考文献
Abstract
No Distinct Cytokine, Chemokine, and Growth Factor Blood Profile Associated With Monkeypox Virus Clade IIb Infected Patients.
Authors:Bangwen E,Berens-Riha N,de Vrij N,Ceulemans A,Brosius I,De Vos E,Pham TT,Bottieau E,van Griensven J,Netongo PM,Van Esbroeck M,Vercauteren K,Van Dijck C,Adriaensen W,Liesenborghs L
Journal:Journal of medical virology
PubMed ID:40156483
Previous studies indicated Clade I monkeypox virus infection to be associated with marked elevation of proinflammatory cytokines. This remains unexplored for Clade II‐associated disease, which has different clinical manifestations and prognosis. We used a 65‐plex cytokine, chemokine, and growth factor (CCG) panel to analyze serum samples of 100 male acute ... More
Immune monitoring of trabectedin therapy in refractory soft tissue sarcoma patients - the IMMUNYON study.
Authors:Rodrigues-Santos P,Almeida JS,Sousa LM,Couceiro P,Martinho A,Rodrigues J,Fonseca R,Santos-Rosa M,Freitas-Tavares P,Casanova JM
Journal:Frontiers in immunology
PubMed ID:40007535
Soft tissue sarcomas (STS) encompass over 50 histologic subtypes, representing more than 1% of solid tumors. Standard treatments include surgical resection and therapies such as anthracyclines or trabectedin for advanced cases, though challenges persist due to the tumor microenvironment’s complexity and limited immune profiling data. This study evaluates Trabectedin therapy ... More
Immune profiling of human vestibular schwannoma secretions identifies TNF-α and TWEAK as cytokines with synergistic potential to impair hearing
Authors:Vasilijic S, Seist R, Yin Z, Xu L, Stankovic KM
Journal:Journal of Neuroinflammation
PubMed ID:39923035
Vestibular schwannoma (VS) is an intracranial tumor arising from the Schwann cells of the vestibular nerve and is an important cause of sensorineural hearing loss (SNHL) in humans. The mechanisms underlying this SNHL are incompletely understood and currently, there are no drugs FDA approved specifically for VS. This knowledge gap ... More
Assessing serum cytokine profiles in inflammatory breast cancer patients using Luminex® technology.
Authors:Yaacoubi-Loueslati B
Journal:Cytokine
PubMed ID:37918053
Inflammatory breast cancer (IBC), accounts for the majority of deaths associated with breast tumors. Because this form is aggressive from its appearance and has a strong metastatic potential. The majority of patients are not diagnosed until late stages, highlighting the need for the development of novel diagnostic biomarkers. Immune mediators ... More
Multiplexing protein and gene level measurements on a single Luminex platform.
Authors:Cook DB, McLucas BC, Montoya LA, Brotski CM, Das S, Miholits M, Sebata TH
Journal:Methods
PubMed ID:30742996
'The ability to simultaneously measure multiple secreted proteins and the corresponding gene expression levels from a single sample is valuable for comprehensive analysis. Bottlenecks to traditional immunoassays and gene expression assays include large sample consumption, time consuming experimental procedures, and complex data analysis.' ... More